Clinical

Dataset Information

0

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer


ABSTRACT: RATIONALE: Drugs used in chemotherapy, such as fluorouracil, leucovorin calcium, oxaliplatin, capecitabine, and irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving the drugs in different combinations may kill more tumor cells. Monoclonal antibodies, such as bevacizumab and cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Giving combination chemotherapy together with bevacizumab or cetuximab may kill more tumor cells. PURPOSE:To evaluate the use of standard (KRAS) and experimental (thymidine phosphorylase, ERCC1 and BRAF) tumor testing can aid in selecting chemotherapy regimens

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2101117 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| phs001570 | dbGaP
| 2046243 | ecrin-mdr-crc
| 2046482 | ecrin-mdr-crc
| 2045339 | ecrin-mdr-crc
| 2026285 | ecrin-mdr-crc
| 2064438 | ecrin-mdr-crc
| 2046289 | ecrin-mdr-crc
| 2053680 | ecrin-mdr-crc
| 2141822 | ecrin-mdr-crc
| 2062077 | ecrin-mdr-crc